Vivus Company Profile (NASDAQ:VVUS)

About Vivus

Vivus logoVIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA (avanafil) for erectile dysfunction (ED). The Company has completed the Phase II studies of Qsymia for the indication of Obstructive Sleep Apnea (OSA) and diabetes. Its Qsymia is available in over 40,000 certified retail pharmacies across the country. Its STENDRA is also approved by the European Commission (EC), under the name, SPEDRA, for the treatment of ED in the Europe. The United States Food and Drug Association approved a Supplemental New Drug Application (sNDA) for STENDRA. STENDRA is indicated to be taken approximately 15 minutes before sexual activity.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: VVUS
  • CUSIP: 92855110
Key Metrics:
  • Previous Close: $1.24
  • 50 Day Moving Average: $1.07
  • 200 Day Moving Average: $1.24
  • 52-Week Range: $0.92 - $2.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.48
  • P/E Growth: -2.11
  • Market Cap: $129.18M
  • Outstanding Shares: 104,181,000
  • Beta: 1.27
  • Net Margins: -75.52%
  • Return on Equity: -291.94%
  • Return on Assets: -19.34%
  • Debt-to-Equity Ratio: -7.50%
  • Current Ratio: 4.77%
  • Quick Ratio: 4.56%
Additional Links:
Companies Related to Vivus:

Analyst Ratings

Consensus Ratings for Vivus (NASDAQ:VVUS) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $1.90 (53.23% upside)

Analysts' Ratings History for Vivus (NASDAQ:VVUS)
DateFirmActionRatingPrice TargetDetails
7/25/2016WallachBeth CapitalSet Price TargetBuy$2.80View Rating Details
5/4/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
3/10/2016Needham & Company LLCReiterated RatingHoldView Rating Details
2/29/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$4.00 -> $1.00View Rating Details
11/6/2014Bank of America Corp.Reiterated RatingUnderperform$4.00 -> $3.00View Rating Details
(Data available from 9/27/2014 forward)


Earnings History for Vivus (NASDAQ:VVUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.31)($0.11)$19.00 million$13.77 millionViewN/AView Earnings Details
5/3/2016Q116($0.21)($0.12)$17.97 million$15.32 millionViewN/AView Earnings Details
3/9/2016Q4($0.12)($0.12)$22.90 million$15.34 millionViewN/AView Earnings Details
11/4/2015Q315($0.17)($0.15)$20.24 million$24.90 millionViewN/AView Earnings Details
7/30/2015Q215($0.23)($0.19)$18.76 million$23.00 millionViewListenView Earnings Details
5/5/2015Q115($0.22)($0.15)$21.80 million$32.20 millionViewN/AView Earnings Details
2/24/2015Q414($0.25)($0.25)$20.00 million$21.70 millionViewListenView Earnings Details
11/5/2014Q314($0.25)($0.10)$21.90 million$33.90 millionViewListenView Earnings Details
8/7/2014Q214($0.28)($0.25)$17.90 million$21.90 millionViewListenView Earnings Details
5/5/2014Q114($0.37)($0.15)$11.40 million$36.70 millionViewN/AView Earnings Details
2/24/2014Q413($0.40)($0.17)$28.20 million$44.06 millionViewListenView Earnings Details
11/5/2013Q313($0.38)($0.48)$21.78 million$27.38 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.44)($0.55)$12.76 million$5.53 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.51)($0.53)$5.22 million$4.10 millionViewN/AView Earnings Details
2/25/2013Q4 2012($0.44)($0.56)$3.09 million$1.97 millionViewN/AView Earnings Details
11/6/2012Q312($0.34)($0.40)$0.35 million$0.04 millionViewN/AView Earnings Details
8/7/2012($0.23)($0.24)ViewN/AView Earnings Details
5/7/2012($0.13)($0.20)ViewN/AView Earnings Details
2/28/2012($0.12)($0.14)ViewN/AView Earnings Details
11/7/2011($0.12)($0.10)ViewN/AView Earnings Details
8/1/2011($0.13)($0.20)ViewN/AView Earnings Details
5/2/2011($0.15)($0.12)ViewN/AView Earnings Details
2/28/2011($0.22)($0.23)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vivus (NASDAQ:VVUS)
Current Year EPS Consensus Estimate: $-0.74 EPS
Next Year EPS Consensus Estimate: $-0.5 EPS


Dividend History for Vivus (NASDAQ:VVUS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Vivus (NASDAQ:VVUS)
Insider Ownership Percentage: 4.50%
Institutional Ownership Percentage: 37.03%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/2/2016Santosh T VargheseInsiderSell12,559$1.07$13,438.13View SEC Filing  
7/1/2016Santosh T VargheseVPSell366$1.21$442.86View SEC Filing  
4/7/2016Santosh T VargheseInsiderSell329$1.65$542.85View SEC Filing  
4/1/2016North Tide Capital, LlcMajor ShareholderBuy2,160$1.40$3,024.00View SEC Filing  
3/31/2016North Tide Capital, LlcMajor ShareholderBuy383,300$1.29$494,457.00View SEC Filing  
3/28/2016North Tide Capital, LlcMajor ShareholderBuy202,000$1.12$226,240.00View SEC Filing  
3/16/2016North Tide Capital, LlcMajor ShareholderBuy500,000$1.21$605,000.00View SEC Filing  
1/1/2016John L SlebirSVPSell2,973$3.04$9,037.92View SEC Filing  
1/8/2015North Tide Capital, LlcMajor ShareholderBuy500,000$3.12$1,560,000.00View SEC Filing  
1/6/2015North Tide Capital, LlcMajor ShareholderBuy476,800$3.04$1,449,472.00View SEC Filing  
1/2/2015North Tide Capital, LlcMajor ShareholderBuy523,200$2.90$1,517,280.00View SEC Filing  
3/11/2014Seth H.Z. FischerCEOBuy3,080$6.07$18,695.60View SEC Filing  
11/11/2013Alexander DennerDirectorBuy566,844$8.59$4,869,189.96View SEC Filing  
9/5/2013Timothy E MorrisCFOSell10,654$11.95$127,315.30View SEC Filing  
9/4/2013Michael J AstrueDirectorBuy10,000$11.96$119,600.00View SEC Filing  
6/27/2013Jon C BiroInsiderBuy2,000$12.85$25,700.00View SEC Filing  
5/29/2013Ernest MarioDirectorBuy15,000$14.68$220,200.00View SEC Filing  
8/20/2012Ernest MarioDirectorBuy5,000$20.75$103,750.00View SEC Filing  
8/10/2012Ernest MarioDirectorBuy20,000$21.74$434,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Vivus (NASDAQ:VVUS)
News IconKeen Investors Find News on VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 23 at 7:24 PM
News IconUnder the Microscope, Zeroing in at VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 23 at 6:43 AM
News IconPenny Stock Investors Keen on Shares of VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 21 at 7:33 PM
News IconPenny Stock Investors Take an Interest in VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 21 at 11:52 AM
News IconUnder the Microscope: Getting a Closer Look at Shares of VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 20 at 6:27 AM
News IconVIVUS, Inc. (VVUS) Stock Rating Reaffirmed by JPMorgan Chase & Co. - DailyQuint (NASDAQ:VVUS) - September 20 at 6:27 AM
News IconSEC Filings: Tahithromos LLC Has Trimmed Its Holding in Vivus INC (VVUS) by $4.57 Million - Chester News (NASDAQ:VVUS) - September 18 at 7:01 AM
News IconShares in Focus: VIVUS, Inc. (NASDAQ:VVUS) Earnings & Targets ... - Frisco Fastball (NASDAQ:VVUS) - September 17 at 6:42 AM
News IconKeen Investors Seek Information on VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 16 at 7:45 PM
News IconKeen Investors Narrowing Their Focus on VIVUS Inc. (NASDAQ:VVUS) - Duncan Research (NASDAQ:VVUS) - September 14 at 8:15 PM
News IconShares in Focus: VIVUS, Inc. (NASDAQ:VVUS) Earnings & Targets Update - Frisco Fastball (NASDAQ:VVUS) - September 10 at 7:04 AM logoETF’s with exposure to VIVUS, Inc. : September 9, 2016 (NASDAQ:VVUS) - September 9 at 7:38 PM
News IconPlacing VIVUS, Inc. (NASDAQ:VVUS) Shares Under the Microscope - National Daily Press (NASDAQ:VVUS) - September 9 at 6:49 AM logoVIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreem (NASDAQ:VVUS) - September 6 at 8:07 PM
News IconUpbeat Stocks in Focus- VIVUS Inc. (NASDAQ:VVUS), Ritchie Bros. Auctioneers (NYSE:RBA), Adams Resources ... - Seneca Globe (NASDAQ:VVUS) - August 30 at 11:29 AM logoVIVUS (VVUS), Auxilium Announce Extension of STENDRA License ... - (NASDAQ:VVUS) - August 29 at 8:06 PM logoVIVUS Extends Return Date of STENDRA Commercial Rights (NASDAQ:VVUS) - August 29 at 8:06 PM logoETF’s with exposure to VIVUS, Inc. : August 26, 2016 (NASDAQ:VVUS) - August 26 at 11:03 AM logoVIVUS INC Financials (NASDAQ:VVUS) - August 12 at 8:20 PM logoETF’s with exposure to VIVUS, Inc. : August 12, 2016 (NASDAQ:VVUS) - August 12 at 8:20 PM logoVIVUS, Inc. :VVUS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:VVUS) - August 11 at 11:40 AM logoVIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:VVUS) - August 9 at 8:33 PM logoEdited Transcript of VVUS earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:VVUS) - August 7 at 7:46 PM logoEarnings Reaction History: VIVUS, Inc., 71.4% Follow-Through Indicator, 6.4% Sensitive - Nasdaq (NASDAQ:VVUS) - August 5 at 8:25 PM logoVIVUS Inc. (VVUS) Jumps 6.67% on August 05 - (NASDAQ:VVUS) - August 5 at 8:25 PM logoVIVUS Reports 2016 Second Quarter Financial Results (NASDAQ:VVUS) - August 5 at 11:17 AM logoVivus Inc.: VIVUS Reports 2016 Second Quarter Financial Results (NASDAQ:VVUS) - August 5 at 11:17 AM logoVIVUS' (VVUS) CEO Seth Fischer on Q2 2016 Results - Earnings Call Transcript (NASDAQ:VVUS) - August 5 at 11:17 AM logoVIVUS Inc. (VVUS) Jumps 6.16% on August 03 - (NASDAQ:VVUS) - August 4 at 8:41 PM logoVivus reports 2Q loss (NASDAQ:VVUS) - August 4 at 8:41 PM logoQ2 2016 VIVUS Inc Earnings Release - After Market Close (NASDAQ:VVUS) - August 4 at 11:29 AM
News IconUpcoming Earnings Report: VIVUS Inc. (NASDAQ:VVUS) - The Voice Registrar (NASDAQ:VVUS) - July 28 at 8:39 PM logoVIVUS Files Lawsuit Against Hetero for Infringement of Stendra Patents (NASDAQ:VVUS) - July 27 at 4:38 PM logoVIVUS Announces Date of 2016 Second Quarter Business Update and Financial Results Teleconference (NASDAQ:VVUS) - July 26 at 4:38 PM logoVIVUS Announces Favorable Markman Ruling in Qsymia® Patent Litigation (NASDAQ:VVUS) - July 22 at 7:59 PM logoVIVUS (VVUS) Announces Receipt of Favorable Markman Decision in Qsymia Patent Spat (NASDAQ:VVUS) - July 22 at 7:59 PM logoVIVUS (VVUS) Announces Receipt of Favorable Markman Decision in Qsymia Patent Spat - (NASDAQ:VVUS) - July 22 at 11:06 AM logoVIVUS holding its ground against would-be generic makers of Qsymia (NASDAQ:VVUS) - July 22 at 7:36 AM logoVIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:VVUS) - July 22 at 6:03 AM logoVivus Begins Q3 With Underwhelming Qsymia Sales - Seeking Alpha (NASDAQ:VVUS) - July 21 at 11:02 AM logoVIVUS Inc. (NASDAQ:VVUS) Fundamental Star Rating Report - CML News (NASDAQ:VVUS) - July 21 at 11:02 AM
News IconVIVUS, Inc. (NASDAQ:VVUS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:VVUS) - July 19 at 8:22 PM
News IconTahithromos LLC Decreased Stake in Vivus INC (NASDAQ:VVUS) by $4.57 Million as Shares Rose - Press Telegraph (NASDAQ:VVUS) - July 19 at 8:22 PM logoVIVUS Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:VVUS) - July 16 at 11:22 AM
News IconCrowd Rating and Earnings Recap for VIVUS, Inc. (NASDAQ:VVUS) - Telanagana Press (NASDAQ:VVUS) - July 15 at 7:12 PM
News IconShares Experiencing a Downtrend: VIVUS Inc. (NASDAQ:VVUS) - TGP (NASDAQ:VVUS) - July 15 at 7:12 PM logoVIVUS, Inc. (NASDAQ:VVUS) Current Analyst Ratings - Fiscal Standard (NASDAQ:VVUS) - July 15 at 7:12 PM
News IconVIVUS, Inc. (NASDAQ:VVUS) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:VVUS) - July 14 at 8:26 PM
News IconHow Many VIVUS, Inc. (NASDAQ:VVUS)'s Analysts Are Bearish? - Consumer Eagle (NASDAQ:VVUS) - July 13 at 8:31 PM logoVIVUS Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:VVUS) - July 12 at 12:07 PM


Vivus (NASDAQ:VVUS) Chart for Tuesday, September, 27, 2016

Last Updated on 9/27/2016 by Staff